Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-26 4:26 pm Purchase |
2024-06-03 | 13D | Inhibrx Biosciences, Inc. INBX |
Kayyem Jon Faiz | 1,149,046 7.900% |
330,471 (+40.37%) |
Filing History |
| 2025-02-26 4:16 pm Purchase |
2024-09-12 | 13D | Inhibrx Biosciences, Inc. INBX |
Mark Lappe | 925,413 6.400% |
164,000 (+21.54%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
BLACKROCK INC BLK |
831,807 5.700% |
831,807 (New Position) |
Filing History |
| 2024-11-14 8:14 pm Purchase |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 1,488,553 9.900% |
1,488,553 (New Position) |
Filing History |
| 2024-06-07 4:23 pm Purchase |
2024-05-29 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 1,787,705 12.300% |
1,787,705 (New Position) |
Filing History |
| 2024-06-03 8:45 pm Purchase |
2024-05-29 | 13D | Inhibrx Biosciences, Inc. INBX |
Kayyem Jon Faiz | 818,575 5.650% |
818,575 (New Position) |
Filing History |
| 2024-06-03 8:43 pm Purchase |
2024-05-29 | 13D | Inhibrx Biosciences, Inc. INBX |
Mark Lappe | 761,413 5.260% |
761,413 (New Position) |
Filing History |
| 2024-05-31 4:30 pm Purchase |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
SANOFI SYNTHELABO SA | 1,157,926 8.000% |
1,157,926 (New Position) |
Filing History |